Drug Discovery News: Breaking Drug Discovery News, Comments and Articles. - Page: 4

16:39 EDT 25th October 2014 | BioPortfolio

Drug Discovery News - Page: 4Twitter RSS

Read the latest Drug Discovery News from around the world, updated every five minutes. Breaking stories from leading news and press agencies, bloggers and experts on Drug Discovery.

Search or Follow Our Drug Discovery - Page: 4 News…

If you are looking for more stories, you may wish to search our extensive news archives for relevant stories: Search for More Drug Discovery - Page: 4 News.
You can also follow our Drug Discovery - Page: 4 news stories on Twitter: @DiscoveryDrug

Showing "drug drug discovery discovery" News Articles 76 to 100 of 27,000+

Friday 24th October 2014

Europe Approves Novel Australian Drug Developed for Rare Sun Disease

The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the European Medicines Agency (EMA). SCENESSE® (afamelanotide 16mg) treats the debilitating genetic disorder porphyria (EPP), or absolute intolerance to sunlight. The fear of lifelong burns requires EPP patient...

UPDATE 1-EU regulator backs continued use of Ariad Pharma's leukaemia drug

Oct 24 (Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug, Iclusig, in its already approved indications to treat certain kinds of leukaemia.

New drug could help in battle against cervical cancer

In Europe patients with recurrent or secondary cancer have a low chance of survival, with only 20-30% experiencing tumour shrinkage after conventional chemotherapy and life expectancy being diagnosed as less than one year for many. A Cancer Research...

EMA committee recommends AstraZeneca's ovarian cancer drug Lynparza

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending AstraZeneca's marketing authorization of ovarian cancer drug Lynparza (olaparib) as monotherapy.

The cancer drug discovery system is broken, global summit hears

Here's our take on the week's top stories.

EU backs drug for rare sun intolerance from Australia's Clinuvel

LONDON, Oct 24 (Reuters) - European patients with a rare genetic disease that causes intolerance to sunlight should soon have a new treatment option, following a green light for a drug from Australia's Clinuvel Pharmaceuticals.

Europe backs continued use of Ariad Pharma's leukaemia drug

Oct 24 (Reuters) - European regulators recommended continued use of Ariad Pharmaceuticals Inc's cancer drug Iclusig in its already approved indications to treat certain kinds of leukaemia.

AstraZeneca cancer drug pipeline gets boost from European green light

LONDON (Reuters) - AstraZeneca's cancer drug pipeline received a boost on Friday, as European regulators recommended approval of an experimental medicine against ovarian cancer.

Shire Q3 Profit Increases; Raises 2014 Adj. Earnings Growth View

SAINT HELIER (dpa-AFX) - Irish drug company Shire Plc.'s (SHP.L, SHPG) third-quarter net income significantly increased to $479.7 million from $278.2 million in the same quarter last year. Earning...

BRIEF-Eckert & Ziegler to be European development partner for drug against pancreatic cancer

Oct 24 (Reuters) - Eckert & Ziegler Strahlen Und Medizintechnik AG :

Cytori gets FDA nod to resume enrolment in ATHENA cardiovascular trial

Cytori Therapeutics has received notification from the US Food and Drug Administration (FDA) that the company has provided additional information sufficient to support continuation of enrollment in its ATHENA cardiovascular trials.

UPDATE 1-AstraZeneca cancer drug pipeline gets boost from European green light

* EMA also backs new drugs from Pfizer, Baxter, Clinuvel (Adds AstraZeneca comment, further details)

Relypsa submits NDA for FDA clearance of hyperkalemia treatment Patiromer FOS

Biopharmaceutical firm Relypsa has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) seeking clearance to market Patiromer for Oral Suspension (Patiromer FOS) to treat hyperkalemia.

Bristol-Myers Squibb Reports Third Quarter 2014 Financial Results

Posts Third Quarter GAAP EPS of $0.43 and Non-GAAP EPS of $0.45 Achieves Significant Regulatory Milestones for PD-1 Inhibitor Opdivo Launches Daklinza-Based Regimens for HCV Patients in Japan and Europe Adjusts 2014 GAAP EPS Guidance Range to $1.15 - $1.25 and Confirms Non-GAAP EPS Guidance Range of...

Results of CPhI Worldwide 2014: Novalik-Pharm and Pharmplanet Signed International Manufacturing Contracts and Presented Its Own Unique Immunomodulator Beta-Immun

Kyiv, Ukraine, October 24, 2014 --(PR.com)-- On October 7-9, Ukrainian pharmaceutical company Novalik-Pharm and its official distributor Pharmplanet took part in the international exhibition in Paris. This year, CPhI Worldwide celebrates its 25th anniversary. Specifically to this date the organizers arranged a competition "Top 25 Success Stories." According to the decision of the jury, ...

Aseptika selected for Discovery Start-Ups 2014 award

Aseptika Limited was selected as one of five winners out of the eighteen strong field of UK start-up companies pitching for the winning prizes at the Discovery Start-Ups 2014 event held on Wednesday, 22nd October at Deloitte’s in London.

AstraZeneca ovarian cancer drug wins European green light

LONDON, Oct 24 (Reuters) - AstraZeneca's cancer drug pipeline received a boost on Friday as European regulators recommended approval of an experimental medicine against ovarian cancer.

Limbkeepers® to be Featured on Upcoming Episode of Innovations with Ed Begley, Jr.

DMG Productions explores advancements in health and medicine. Lyme, CT (PRWEB) October 24, 2014 Limbkeepers® announced today that they will be featured in an upcoming episode of Innovations with Ed Begley Jr, airing 1st QTR 2015 via Discovery Channel. Dates and show times TBA. In this episode, Innovations will focus on Limbkeepers® non compression knit sleeves, a new solution helping to...

GE Healthcare Life Sciences wins prestigious bioprocessing industry award

CHALFONT ST. GILES, UK – 24 October 2014 – GE Healthcare Life Sciences (NYSE:GE) has won a BioProcess International (BPI) industry award for excellence in bioprocessing facility design.  The BPI awards, voted for by bioprocess experts and hosted by industry publication BioProcess International, recognize outstanding products, services, partnerships and people that have had the greatest positi...

10.23.14 -- ISPE's Framework For The Prevention Of Drug Shortages

10/23/14Pharmaceutical Online Newsletter

Drug Repackaging Company Recalls Tablets Due to Packaging Mix-Up

Contract Packaging Resources issued a voluntary recall of naproxen sodium tablets because some cartons contain bottles of ibuprofen.

Ashland Opens a Pharmaceutical Center in Delaware

Ashland Specialty Ingredients opened a drug development and bioavailability enhancement facility in Wilmington, Delaware.

FDA approves new treatment for rare form of hemophilia

The U.S. Food and Drug Administration yesterday approved Obizur [Antihemophilic Factor (Recombinant), Porcine Sequence] for the treatment of bleeding episodes in adults with acquired hemophilia A (acquired Factor VIII [FVII] deficiency).

ImmunoGen, Inc. Reports First Quarter Fiscal Year 2015 Financial Results

− Conference Call Today at 8:00 am ET− Advancing pipeline of wholly owned therapeutic candidates: IMGN853 in initial evaluation of efficacy in treatment of targeted ovarian and endometrial cancers; new IMGN529 clinical data to be reported at ASH; dose-finding evaluation of IMGN289 ongoing; IMGN779 advancing towards IND submiss...

Cancer drug discovery system is broken, global summit hears

The global system for discovering new cancer drugs is ‘broken’, and failing to turn dramatic scientific advances into enough innovative, game-changing medicines, a world-leading UK expert has warned. Professor Paul Workman, Interim Chief Executi...


Search BioPortfolio:
Loading
Advertisement
Advertisement

News Quicklinks